查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413661

萬古黴素市場：按類型、劑型、給藥途徑、應用、分銷管道 - 全球預測 2024-2030

Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年萬古黴素市場規模為6.9323億美元，2024年將達7.4153億美元，2030年將達9.9287億美元，複合年成長率為5.26%。

萬古黴素全球市場

主要市場統計
基準年[2023] 6.9323 億美元
預測年份 [2024] 74153萬美元
預測年份 [2030] 99287萬美元
複合年成長率（%） 5.26%
萬古黴素市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估萬古黴素市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對萬古黴素市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-萬古黴素市場規模及預測是多少？

2-萬古黴素市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-萬古黴素市場的技術趨勢和法律規範是什麼？

4-萬古黴素市場主要供應商的市場佔有率是多少？

5-進入萬古黴素市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 細菌感染疾病在全球蔓延
      • 政府的感染控制優勢策略
      • 對非專利替代品的需求不斷成長
    • 抑制因素
      • 萬古黴素對健康的不良影響
    • 機會
      • 最佳化萬古黴素輸送的創新方法
      • 致力於正確使用萬古黴素的教育工作
    • 任務
      • 萬古黴素替代品的存在
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章萬古黴素市場：依類型

  • Ampicillin
  • 氯黴素
  • Daptomycin
  • 利奈唑胺
  • 奎努普汀

第7章 萬古黴素市場：依型態

  • 膠囊
  • 口服液（液體）
  • 粉末

第8章萬古黴素市場：依給藥途徑

  • 靜脈
  • 口服

第9章萬古黴素市場：依應用分類

  • 結腸炎和大腸發炎
  • 肺部感染疾病
  • 敗血症
  • 皮膚和軟組織感染疾病

第10章萬古黴素市場：依分銷管道分類

  • 門診藥房
  • 醫院藥房
  • 網路藥房

第11章 美洲萬古黴素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章 亞太地區萬古黴素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東、非洲萬古黴素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第15章競爭產品組合

  • 主要公司簡介
    • Alvogen
    • Aphios Corporation
    • CJ CheilJedang Corporation
    • Eli Lilly and Company
    • Enanta Pharmaceuticals, Inc.
    • GlaxoSmithKline PLC
    • Helix BioMedix, Inc.
    • Innovation Pharmaceuticals Inc.
    • LegoChem Biosciences, Inc.
    • Lytix Biopharma AS
    • MGB Biopharma
    • Microbiotix, Inc.
    • MicuRx Pharmaceuticals
    • Nabriva Therapeutics GmbH
    • North China Pharmaceutical Group Co., Ltd.
    • NovaBay Pharmaceuticals, Inc.
    • NovoBiotic Pharmaceuticals, LLC
    • Oragenics, Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sealife Pharma GmbH
    • VIANEX
    • Xellia Pharmaceuticals ApS
    • Zealand Pharma A/S
    • Zhejiang Hisun Pharmaceutical Co., Ltd.
    • Zhejiang Pharmaceutical Co., Ltd.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C99656

[197 Pages Report] The Vancomycin Market size was estimated at USD 693.23 million in 2023 and expected to reach USD 741.53 million in 2024, at a CAGR 5.26% to reach USD 992.87 million by 2030.

Global Vancomycin Market

KEY MARKET STATISTICS
Base Year [2023] USD 693.23 million
Estimated Year [2024] USD 741.53 million
Forecast Year [2030] USD 992.87 million
CAGR (%) 5.26%
Vancomycin Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vancomycin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vancomycin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vancomycin Market, highlighting leading vendors and their innovative profiles. These include Alvogen, Aphios Corporation, CJ CheilJedang Corporation, Eli Lilly and Company, Enanta Pharmaceuticals, Inc., GlaxoSmithKline PLC, Helix BioMedix, Inc., Innovation Pharmaceuticals Inc., LegoChem Biosciences, Inc., Lytix Biopharma AS, MGB Biopharma, Microbiotix, Inc., MicuRx Pharmaceuticals, Nabriva Therapeutics GmbH, North China Pharmaceutical Group Co., Ltd., NovaBay Pharmaceuticals, Inc., NovoBiotic Pharmaceuticals, LLC, Oragenics, Inc., Pfizer Inc., Sanofi SA, Sealife Pharma GmbH, VIANEX, Xellia Pharmaceuticals ApS, Zealand Pharma A/S, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zhejiang Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Vancomycin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Ampicillin
    • Chloramphenicol
    • Daptomycin
    • Linezolid
    • Quinupristin
  • Form
    • Capsule
    • Oral Solution (Liquid)
    • Powder
  • Route of Administration
    • Intravenous
    • Oral
  • Application
    • Colitis & Intestinal Inflammation
    • Lung Infection
    • Sepsis
    • Skin Soft Tissue Infection
  • Distribution Channel
    • Ambulatory Pharmacy
    • Hospital Pharmacy
    • Online Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vancomycin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vancomycin Market?

3. What are the technology trends and regulatory frameworks in the Vancomycin Market?

4. What is the market share of the leading vendors in the Vancomycin Market?

5. Which modes and strategic moves are suitable for entering the Vancomycin Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vancomycin Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of bacterial infections across the globe
      • 5.1.1.2. Favorable government strategies for infection control
      • 5.1.1.3. Rising need for generic alternatives
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of vancomycin
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative approaches to optimize the delivery of vancomycin
      • 5.1.3.2. Promising educational initiatives for adequate vancomycin use
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative substitutes of vancomycin
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Vancomycin Market, by Type

  • 6.1. Introduction
  • 6.2. Ampicillin
  • 6.3. Chloramphenicol
  • 6.4. Daptomycin
  • 6.5. Linezolid
  • 6.6. Quinupristin

7. Vancomycin Market, by Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Oral Solution (Liquid)
  • 7.4. Powder

8. Vancomycin Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Oral

9. Vancomycin Market, by Application

  • 9.1. Introduction
  • 9.2. Colitis & Intestinal Inflammation
  • 9.3. Lung Infection
  • 9.4. Sepsis
  • 9.5. Skin Soft Tissue Infection

10. Vancomycin Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Ambulatory Pharmacy
  • 10.3. Hospital Pharmacy
  • 10.4. Online Pharmacy

11. Americas Vancomycin Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vancomycin Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vancomycin Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Alvogen
    • 15.1.2. Aphios Corporation
    • 15.1.3. CJ CheilJedang Corporation
    • 15.1.4. Eli Lilly and Company
    • 15.1.5. Enanta Pharmaceuticals, Inc.
    • 15.1.6. GlaxoSmithKline PLC
    • 15.1.7. Helix BioMedix, Inc.
    • 15.1.8. Innovation Pharmaceuticals Inc.
    • 15.1.9. LegoChem Biosciences, Inc.
    • 15.1.10. Lytix Biopharma AS
    • 15.1.11. MGB Biopharma
    • 15.1.12. Microbiotix, Inc.
    • 15.1.13. MicuRx Pharmaceuticals
    • 15.1.14. Nabriva Therapeutics GmbH
    • 15.1.15. North China Pharmaceutical Group Co., Ltd.
    • 15.1.16. NovaBay Pharmaceuticals, Inc.
    • 15.1.17. NovoBiotic Pharmaceuticals, LLC
    • 15.1.18. Oragenics, Inc.
    • 15.1.19. Pfizer Inc.
    • 15.1.20. Sanofi SA
    • 15.1.21. Sealife Pharma GmbH
    • 15.1.22. VIANEX
    • 15.1.23. Xellia Pharmaceuticals ApS
    • 15.1.24. Zealand Pharma A/S
    • 15.1.25. Zhejiang Hisun Pharmaceutical Co., Ltd.
    • 15.1.26. Zhejiang Pharmaceutical Co., Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. VANCOMYCIN MARKET RESEARCH PROCESS
  • FIGURE 2. VANCOMYCIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. VANCOMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VANCOMYCIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. VANCOMYCIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VANCOMYCIN MARKET DYNAMICS
  • FIGURE 7. VANCOMYCIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. VANCOMYCIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. VANCOMYCIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. VANCOMYCIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. VANCOMYCIN MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. VANCOMYCIN MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. VANCOMYCIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. VANCOMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VANCOMYCIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. VANCOMYCIN MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VANCOMYCIN MARKET SIZE, BY CHLORAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VANCOMYCIN MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VANCOMYCIN MARKET SIZE, BY LINEZOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VANCOMYCIN MARKET SIZE, BY QUINUPRISTIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 12. VANCOMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. VANCOMYCIN MARKET SIZE, BY ORAL SOLUTION (LIQUID), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VANCOMYCIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. VANCOMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. VANCOMYCIN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. VANCOMYCIN MARKET SIZE, BY COLITIS & INTESTINAL INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. VANCOMYCIN MARKET SIZE, BY LUNG INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. VANCOMYCIN MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. VANCOMYCIN MARKET SIZE, BY SKIN SOFT TISSUE INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. VANCOMYCIN MARKET SIZE, BY AMBULATORY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. VANCOMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. VANCOMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VANCOMYCIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VANCOMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VANCOMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. VANCOMYCIN MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. VANCOMYCIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. VANCOMYCIN MARKET LICENSE & PRICING